Veterans advocate for ibogaine to combat PTSD

Veterans are increasingly advocating for the use of ibogaine, a psychedelic substance, to treat post-traumatic stress disorder (PTSD) and other conditions, despite its current illegal status in the United States. A non-profit organization, Veterans Exploring Treatment Solutions (VETS), founded by Navy SEAL veteran Marcus Capone and his wife Amber, has facilitated ibogaine treatment for over 1,400 veterans, with 93% reporting positive outcomes, according to KRIS 6 News.

What the treatment involves

Ibogaine is derived from the iboga plant, native to Central Africa, and has been traditionally used in spiritual healing practices. The treatment is believed to enhance neuroplasticity, allowing the brain to form new neural connections and repair damaged pathways. This potential makes it a promising option for addressing PTSD, addiction, and traumatic brain injuries.

Regulatory context

Despite its potential benefits, ibogaine is not approved by the U.S. Food and Drug Administration (FDA) and remains illegal in the United States. This legal barrier forces veterans seeking treatment to travel abroad, primarily to Mexico, where the treatment is available. VETS provides grants to veterans to help cover the costs of these international treatments.

Why it matters

The high suicide rate among veterans post-9/11 underscores the urgent need for effective treatment options. Traditional medications often fail to address the complex needs of veterans, leaving many to seek alternative therapies like ibogaine. The advocacy for ibogaine is gaining traction among lawmakers, who are beginning to consider legislative changes to make the treatment more accessible within the U.S.

Personal stories

Steve Viola, a Navy SEAL veteran, shared his transformative experience with ibogaine, noting a newfound ability to engage with his surroundings. This personal testimony, along with the Capones' efforts, highlights the potential impact of ibogaine on veterans' lives.

The push for ibogaine access reflects a broader movement towards exploring alternative treatments for PTSD and related conditions, emphasizing the need for continued research and legislative support.

"Reporting based on KRIS 6 News. Read the original: [link]."